Restaurant Brands International Inc. (NYSE:QSR) last session’s volume of 1.83 million shares was higher than its average volume of 0.94 million shares. The stock, after opening at $59.73, hit $60.85 through the close by scoring 2.18%.Restaurant Brands International Inc. (QSR) Analyst Opinion
Restaurant Brands International Inc. has a consensus outperform rating from 15 Wall Street analysts, and the number of shares currently sold short amount to at least 2.63% of shares outstanding. The stock spiked 3.15% last month and is up 27.68 this year. Wall Street is only getting more bullish on the stock, with 10 of analysts who cover QSR having a buy-equivalent rating. Analysts have placed a $55.46 price target on Restaurant Brands International Inc., suggesting a -8.86% decline from recent close. It’s currently trading about -2.56% below its 52-week high.Restaurant Brands International Inc. Earnings Surprise
Restaurant Brands International Inc. (QSR) surprised the stock market in its last reported earnings when it earned $0.49 a piece versus the consensus-estimated $0.45. Its revenue totaled $1.26 billion down -13.39% from the previous quarter.
This stock (QSR) is ahead of its 52-week low with 54.91%. Its last month’s stock price volatility remained 2.5% which for the week stands at 2%. The share price has moved forward from its 20 days moving average, trading at a distance of 1.66% and stays 4.25% away from its 50 days moving average. Over the last five days, shares have managed 5.96% gains and now is up 18.87% since hitting its 200-day moving average of $53.96. Restaurant Brands International Inc. (QSR) has made its way to a 12-month gain of 44.26%.
Turning to Repros Therapeutics Inc. (NASDAQ:RPRX), its shares were trading at $0.34 a retreat of $-0.02, on the trading floor. The stock, after opening at $0.35, touched a high of $0.37 before paring much of its gains. So far, analysts are sticking with their neutral recommendations with the consensus call at 2. Repros Therapeutics Inc. has 0 buy ratings, 0 holds and 0 sells even after the stock tumbled -86.21% from its high of $2.48 to a $10.6 million market value through last close.Repros Therapeutics Inc. (RPRX) Consensus Price Target
The company’s consensus rating on Reuter’s scale improved from 1.5 to 2 during a month. Analysts set a 12-month price target of $5.5 a share. The target implies a 1517.65% spike from where the shares are currently trading. Also, the current price highlights a discount of 1370.59% to analysts’ high consensus price target.Repros Therapeutics Inc. (NASDAQ:RPRX) Intraday Trading
The counter witnessed a trading volume of 0.55 million shares versus an average volume of 0.26 million shares during last trading session. Its last month’s stock price volatility remained 16.14% which for the week approaches 13.35%. The lowest price the stock reached in the last trading day was $0.33 and compares with the $0.33 52-week low. The stock recovered -2.29% since its low point and has performed -74.09% year-to-date.